1. Home
  2. RGEN vs GMED Comparison

RGEN vs GMED Comparison

Compare RGEN & GMED Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Repligen Corporation

RGEN

Repligen Corporation

HOLD

Current Price

$165.71

Market Cap

8.2B

Sector

Health Care

ML Signal

HOLD

Logo Globus Medical Inc.

GMED

Globus Medical Inc.

HOLD

Current Price

$88.52

Market Cap

11.7B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
RGEN
GMED
Founded
1981
2003
Country
United States
United States
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Medical/Dental Instruments
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
8.2B
11.7B
IPO Year
N/A
2012

Fundamental Metrics

Financial Performance
Metric
RGEN
GMED
Price
$165.71
$88.52
Analyst Decision
Buy
Buy
Analyst Count
10
15
Target Price
$174.90
$92.42
AVG Volume (30 Days)
630.5K
1.4M
Earning Date
10-28-2025
11-06-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
358.86
EPS
0.03
3.08
Revenue
$707,890,000.00
$2,769,804,000.00
Revenue This Year
$17.84
$16.86
Revenue Next Year
$12.44
$8.05
P/E Ratio
$5,365.43
$28.72
Revenue Growth
11.74
11.75
52 Week Low
$102.97
$51.79
52 Week High
$182.52
$94.93

Technical Indicators

Market Signals
Indicator
RGEN
GMED
Relative Strength Index (RSI) 56.56 59.75
Support Level $156.01 $84.70
Resistance Level $167.74 $88.15
Average True Range (ATR) 4.38 1.94
MACD -0.10 -0.72
Stochastic Oscillator 75.62 58.11

Price Performance

Historical Comparison
RGEN
GMED

About RGEN Repligen Corporation

Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies. Its customers include biopharmaceutical companies, contract development and manufacturing organizations, or CDMOs, and other life science companies. It sells four main product categories: filtration (including fluid management) is the largest category and was 58% of 2024 revenue, while chromatography, proteins, and process analytics were 19%, 12%, and 9%, respectively. Customers in North America, Europe, and Asia Pacific contributed 44%, 37%, and 19% of revenue, respectively.

About GMED Globus Medical Inc.

Globus Medical Inc is a medical device company that develops and provides healthcare products and solutions to hospitals, physicians, and surgical centers. The firm's products are organized into two categories: musculoskeletal solutions, which include medical devices and instruments used mostly for spinal and orthopedic procedures, and enabling technologies, which include computer systems developed for enhancing surgical capabilities. The vast majority of the company's revenue is generated from musculoskeletal solutions products, and more than half of the revenue is earned in the United States. It also has its presence internationally.

Share on Social Networks: